- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Athersys Inc+ Add to Watchlist
ATHX:US2.1200 USD 0.0600 2.91%
As of 20:10:00 ET on 12/19/2013.
Company Profile for Athersys Inc (ATHX)
Athersys Incorporated is a clinical-stage biotechnology company. The Company develops allogeneic stem cell products that focus on treating inflammatory and immune disorders, neurological conditions, cardiovascular disease, and other conditions.
Key Executives for Athersys Inc (ATHX)
|Gil Van BokkelenChairman/CEO/Co-Founder||William O Lehmann Jr "BJ"President/COO/Secretary|
|John J HarringtonExec VP/Chief Scientific Ofcr||Robert J DeansExec VP:Regenerative Medicine|
|Laura K CampbellVP:Finance|